ENOV PEER ANALYSIS

Enovis Corp — metric-by-metric comparison with peers and the industry median

ENOVEnovis Corp

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

ENOVIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ENOV	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
P/E	—	—	23.72	20.56●	122.41	596.83	27.44
P/B	0.87	-74.16●	4.23	2.48	13.36	1.08	2.48
EV/EBITDA	—	—	14.87	9.88●	25.46	10.93	15.23
P/S	0.56●	243.16	3.47	2.09	7.66	1.18	2.66

Financial Health
Metric	ENOV	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Current Ratio	2.04	6.57●	2.46	2.57	2.25	3.58	3.28
Debt/Equity	95.5%	-22.6%●	22.1%	62.9%	35.0%	1.0%	44.7%
NetDebt/EBITDA	-1.84●	0.71	0.42	1.72	0.42	-1.64	0.82

Profitability
Metric	ENOV	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Net Margin	-49.9%	-3,684.6%	14.6%●	10.1%	6.3%	0.2%	-5.7%
ROE	-55.5%	—	18.1%●	12.1%	12.9%	0.2%	-8.6%
ROA	-26.1%	-264.3%	12.4%●	6.1%	8.0%	0.2%	-6.4%
EBITDA Margin	-32.8%	-818.8%	24.0%	25.6%	30.6%●	9.4%	5.2%

Growth + Dividend
Metric	ENOV	4DX	COH	SN	ONCSM	MEDTR	Ind. Median
Rev. Growth	6.0%	-26.0%	2.0%	—	39.1%●	6.5%	7.4%
NI Growth	—	—	-6.8%●	—	—	-62.9%	16.7%
Div. Yield	—	—	3.6%●	3.5%	0.0%	1.1%	1.1%
Payout	—	—	81.5%	52.8%	0.0%	656.3%	39.0%

Valuation
Metric	ENOV	IRMD	QDEL	INSP	AORT	PRCT	Ind. Median
P/E	—	55.04	—	10.28●	101.97	—	27.44
P/B	0.87	13.19	0.67●	1.70	2.65	3.42	2.48
EV/EBITDA	—	—	—	13.65●	21.44	—	15.23
P/S	0.56	15.06	0.47●	1.47	2.60	3.69	2.66

Financial Health
Metric	ENOV	IRMD	QDEL	INSP	AORT	PRCT	Ind. Median
Current Ratio	2.04	7.13●	1.43	6.34	3.28	6.73	3.28
Debt/Equity	95.5%	—	155.3%	3.7%●	57.3%	14.9%	44.7%
NetDebt/EBITDA	-1.84	—	-4.98●	-3.17	3.11	2.11	0.82

Profitability
Metric	ENOV	IRMD	QDEL	INSP	AORT	PRCT	Ind. Median
Net Margin	-49.9%	27.4%●	-45.6%	14.3%	2.5%	-31.8%	-5.7%
ROE	-55.5%	25.0%●	-49.9%	18.4%	3.1%	-27.8%	-8.6%
ROA	-26.1%	21.8%●	-20.0%	16.0%	1.4%	-20.4%	-6.4%
EBITDA Margin	-32.8%	37.4%●	-20.7%	8.8%	14.2%	-28.6%	5.2%

Growth + Dividend
Metric	ENOV	IRMD	QDEL	INSP	AORT	PRCT	Ind. Median
Rev. Growth	6.0%	14.8%	-3.9%	8.9%	17.6%	29.3%●	7.4%
NI Growth	—	19.3%	—	97.2%●	—	—	16.7%
Div. Yield	—	0.8%	—	—	—	—	1.1%
Payout	—	65.4%	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ENOV

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.